Thirteen non-diabetic renal transplant recipients had various aspects of carbohydrate and ipid metabolism studied before and after conversion from cyclosporin A to azathioprine. No patient had a glucose tolerance test result diagnostic of diabetes meflitus before conversion, and there was no change in fasting glucose or immunoreactive insulin values after conversion. There was, however, a fail in the area under the curve of the glucose tolerance test values after conversion. Furthermore, fasting serum cholesterol and triglyceride concentrations fell significantly after conversion. No change in the concentration of high density lipoprotein cholesterol was detected.
Introduction
Cyclosporin A is now extensively used in organ transplantation and is both nephrotoxic and hepatotoxic. ' Recently it has been suggested that its use in pancreatic transplant recipients results in a deterioration in glucose metabolism as compared with azathioprine2 but no other adverse metabolic effects have been noted.
Present series PATIENTS AND METHODS
Thirteen non-diabetic cadaveric renal transplant recipients (mean age 39-6 years; range 21-64) were studied three months after transplantation, when immunosuppression was with cyclosporin A (mean dose 8-6 (SEM 0-6) mg/kg/day), and again four months after transplantation, after successful conversion to azathioprine (100-150 mg/day). At both times the patients also received prednisolone 30 mg on alternate days. Patients took a normal diet, and when possible all other medication was left unchanged.
A 75 g oral glucose tolerance test was performed, and blood was obtained for estimation of fasting lipid and serum insulin values and for renal and hepatic function tests.
RESULTS
The trough plasma cyclosporin A concentration before conversion was 143 (SEM 30) 1ig/l. There was no change in body weight over the conversion period but there was a highly significant fall in serum cholesterol and triglyceride concentrations, although high density lipoprotein cholesterol did not change ( 
<0-01
Conversion: SI to traditional units-Creatinine: 1 Rmol/lA0-01 mg/100 ml.' Glucose:
I mmol/1=18 mg/100 ml. Cholesterol: 1 mmol/1-38-6mg/100 ml. Triglyceride: 1 mmol/A-885 mg/ 100 ml.
centration after conversion (p<005). There was also a fall in the area under the curve of the glucose tolerance test values after conversion but no change in fasting glucose or insulin concentrations.
Discussion
The known reversible nephrotoxic potential ofcyclosporin A was confirmed despite plasma cyclosporin concentrations being within the therapeutic range. Fasting glucose values did not change on conversiont, which agrees with the European multicentre-study comparing the two forms of immunosuppression. The area under the curve of the glucose tolerance test values, however, did fall on conversion. Prednisolone affects carbohydrate metabolism and, although the dose of prednisolone was unaltered, cyclosporin A has been shown to reduce prednisolone metabolisms and may therefore potentiate its effects. Changes in renal function may also contribute to a reduction in the area under the curve by virtue of a change in insulin resistance, although no change in fasting insulin concentrations was detected.
Serum'lipid abnormalities are common in uraemia and persist after transplantation, possibly contributing to the high incidence of atherosclerotic vascular disease in these patients. 4 Our results suggest that the use ofcyclosporin A is associated with an inferior lipid profile as compared with azathioprine, at least in the early postoperative'period. To the extent that lipid abnormalities after transplantation may contribute to atherosclerotic vascular disease, this may be important when the drug is used long term.
